Intermediate risk Advanced Renal Cell Cancer

Intermediate Risk Advanced Renal Cell Cancer

Intermediate risk advanced renal cell cancer is a type of late-stage kidney cancer in which the cancer has spread beyond the kidney and may have spread to other parts of the body. It is the most advanced form of kidney cancer and carries with it a higher risk of death.

Treatment for intermediate risk advanced renal cell cancer includes a combination of medications and sometimes surgery. The medical treatments used are called targeted therapies and involve taking drugs that specifically target the cancer cells, while leaving healthy cells unharmed.

Targeted therapies for intermediate risk advanced renal cell cancer include VEGF inhibitors, mTOR inhibitors, and tyrosine kinase inhibitors. VEGF inhibitors work by blocking the pathways that tumors use for their growth, while mTOR inhibitors work by blocking the pathways that cancer cells use to make proteins that allow cancer cells to grow. Tyrosine kinase inhibitors also work by blocking pathways that cancer cells use to make and maintain proteins that allow cancer cells to grow.

Surgery may also be used to treat intermediate risk advanced renal cell cancer. This involves removing part or all of the cancer-containing organ (such as the kidney or adrenal gland) as well as nearby lymph nodes to help prevent the cancer from spreading further.

Other treatments for intermediate risk advanced renal cell cancer may include radiation therapy, cryotherapy (freezing of cancer cells), immunotherapy (treating the body’s immune system to help fight the cancer), and hormone therapy (to reduce the levels of hormones in the body that cause cancer cells to grow).

Prognosis

The prognosis for intermediate risk advanced renal cell cancer is variable and depends on several factors such as the stage of the cancer and the size and location of the tumor. Generally, patients with this type of cancer have a slightly better prognosis than those with advanced high-risk cancer, but it is still serious.

It is important to remember that no two patients are the same and the outcome of any treatment and the prognosis will depend on individual factors, such as the patient’s age, general health, and the stage of the cancer. Talk with your doctor to understand your individual prognosis and how best to combat the cancer in your particular case.